RxDoctor Payments DataLook up a doctor →

Gina Mangin, PA

Physician Assistant · Orlando, FLNPI 1861450553

Payments from drug & device makers

$300,250in general payments, 2019–2025

Across 868 payments — averaging $345.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$90K
  • AbbVie$76K
  • Regeneron Healthcare Solutions, Inc.$51K
  • Incyte Corporation$26K
  • Dermavant Sciences, Inc.$22K
  • Novartis$8K
  • plus $27K from 22 others

What the payments were for

  • Consulting fees$46,99716%
  • Speaking & faculty fees$169,51656%
  • Travel & lodging$62,15121%
  • Food & beverage$21,0787%
  • Education$5070%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$300,250 in reported general payments places this provider in the 95th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$106,262
Medicare patients
531
Services billed
2,000

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept14$118,423
RinvoqUpadacitinib12$86,357
Clobetasol Propionate52$2,047
Tacrolimus11$2,027
Ketoconazole81$1,235
Fluorouracil11$845
Triamcinolone Acetonide88$675
Doxycycline Hyclate30$647
Fluocinonide21$600
Mupirocin42$351
Hydroxyzine Hcl18$87

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq$76,112$86,35712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →